A1 Refereed original research article in a scientific journal

Di/Oligomerization of GPCRs-Mechanisms and Functional Significance




AuthorsRivero-Muller A, Jonas KC, Hanyaloglu AC, Huhtaniemi I

EditorsGiraldo JC

PublisherELSEVIER ACADEMIC PRESS INC

Publishing placeSAN DIEGO; 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA

Publication year2013

JournalProgress in Molecular Biology and Translational Science

Journal name in sourceOligomerization in Health and Disease

Journal acronymProg.Molec.Biol.Transl.Sci.

Volume117

First page 163

Last page185

Number of pages23

ISBN978-0-12-386931-9

ISSN1877-1173

DOIhttps://doi.org/10.1016/B978-0-12-386931-9.00007-6


Abstract
Initially considered as strict and rigid monomers, GPCRs have shown an ever-increasing flexibility in the number of intermolecular interactions they can participate in. Few rules can be applied to all members of this receptor superfamily, as the functional roles of resulting dimers or oligomers vary widely from biosynthesis, functional complementation, enhancement and control of signaling, positive and negative cooperativity, signal desensitization, membrane trafficking, and pharmacological diversity, among others. Receptor dimerization/oligomerization is a challenging phenomenon to disentangle even in vitro and thus in vivo evidence for its functional significance requires employment of a variety of cutting-edge techniques. Nevertheless, the evidence for GPCR di/oligomerization at the physiological level is mounting and has begun to shed light on an intricate network of interactions that challenge the previous knowledge on how this family of receptors function. Here, we summarize the evidence for GPCR di/oligomerization in living organisms with a particular focus of their involvement in health and disease



Last updated on 2024-26-11 at 20:08